Resultados de la búsqueda 121-130 of 11107 for emerging infectious diseases
Page 1.
This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...
... disease progression, assess the need for treatment, and assess infection rates. Novel SEQUEnced Immunotherapy With Anti-angiogenesis And Chemotherapy In ...
... disease progression, assess the need for treatment, and assess infection rates. 3D Surface Scanning. Scottsdale/Phoenix, Ariz. The purpose of this study is ...
... disease progression, assess the need for treatment, and assess infection rates. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer ...
... disease progression, assess the need for treatment, and assess infection rates. Pre-myeloid Cancer and Bone Marrow Failure Clinic Study. Rochester, Minn ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?